ARCHIVES

NC-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Funding opportunities listed.

May 28, 2004

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988